Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Explore options for retirement accounts at 50. Make informed choices to secure your financial future.
24,046 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
AMD just struck a landmark deal with a global AI cloud leader. This article breaks down what the contract means for r...
A heated public dispute over tariffs erupts after a Supreme Court ruling on emergency tariffs, with Treasury Secretar...
Investor-focused guide to perimeter solutions earnings. Learn how revenue, margins, and cash flow shape PRM stock pro...
Institutional buyers push further into digital assets even as skeptical headlines persist. This report examines wheth...
When a stock drops hard after earnings, it’s easy to panic. This guide explains why pinterest stock just crashed and ...
Investors are buzzing about XPeng as xpeng stock winning this week suggests growth catalysts could unfold. This guide...
Lumentum Holdings stock zoomed after a positive investor briefing at a major industry conference and a rising price t...
Peloton has swung from hype to hardship, but its AI-driven pivot could reshape its fortunes. This guide explains what...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
Insider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
Unlock a practical, reader-friendly breakdown of Rapid Micro's Q1 2026 results. This guide translates the transcript ...